SCHEMBL20865232

SCHEMBL20865232

CC1COc2cc3ncnc(Nc4cccc(Br)c4F)c3cc2O1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20865335 0.88 EGFR (0.74) EGFR
SCHEMBL26750372 0.87 EGFR (0.70) EGFR
SCHEMBL26750527 0.87 EGFR (0.70) EGFR
SCHEMBL20865245 0.87 EGFR (0.72) EGFR
SCHEMBL29394159 0.87 EGFR (0.72) EGFR
SCHEMBL20865222 0.87 EGFR (0.72) EGFR
SCHEMBL20856929 0.87 EGFR (0.72) EGFR
SCHEMBL26750422 0.87 EGFR (0.68) EGFR
SCHEMBL24328870 0.85 EGFR (0.70) EGFR
SCHEMBL24328613 0.85 EGFR (0.70) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081447-A1 EGFR INHIBITORS FOR TREATING LUNG CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-04-18 WO disclosed
WO-2019067543-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-04-04 WO disclosed